Elagolix Nitroso Impurity
Also known as: Elagolix Nitrosamine Impurities or nitrosamine impurities of Elagolix| Product Name | Elagolix Nitroso Impurity |
|---|---|
| Alternate Names | Elagolix Impurities, Impurities of Elagolix |
| CAT No. | CS-EO-01535 |
| CAS No. | Not Available |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 660.59 g/mol |
| Mol. For. | C₃₂H₂₉F₅N₄O₆ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Elagolix |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Elagolix is a drug used to treat endometriosis and uterine fibroids. It is a gonadotropin-releasing hormone (GnRH) antagonist, meaning it blocks the effects of GnRH in the body. However, during the manufacturing process, a nitroso impurity can be formed as a byproduct. This impurity, known as Elagolix Nitroso Impurity, or ENI, is a potential concern due to its potential toxicity.
ENI is classified as a nitroso compound, which means it contains a nitrogen and oxygen atom bonded together by a double bond. Nitroso compounds have been shown to be mutagenic and carcinogenic in animal studies, and as a result, ENI is considered a potential impurity of concern in the manufacturing of Elagolix.
To ensure the safety of Elagolix, manufacturers must closely monitor ENI levels during the production process and take steps to minimize its formation. Regulatory agencies such as the FDA have set limits on the acceptable levels of ENI in Elagolix to ensure patient safety.
Overall, while ENI is a potential impurity of concern in the manufacturing process of Elagolix, strict monitoring and control measures are in place to ensure the drug is safe for use.
Get an Instant Quote
Related Compounds
O-Demethyl elagolix | Elagolix Impurity G | Elagolix Impurity H | Elagolix Keto Impurity | Elagolix Impurity 19 | N-Nitroso Elagolix sodium s-isomer | Elagolix RC 1 | Elagolix N-oxide impurity | Elagolix (S)-enantiomer | N-Nitroso des 2-fluoro-3-methoxyphenyl Elagolix bromo impurity | N-Nitroso Elagolix Ethyl ester impurity | Elagolix Impurity 15 | Elagolix Dialkylated sodium salt Impurity | Elagolix Impurity 8 HCl salt | N-Nitroso des bromo des 2-fluoro-3-methoxyphenyl Elagolix impurity | Sodium (R)-4-((2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-d | Elagolix N-oxide Impurity | Elagolix Impurity N |